Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Propanc Biopharma Inc (PPCB)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTHER OTC]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTHER OTC]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 383
  • Shares Outstanding, K 38,320
  • Annual Sales, $ 0 K
  • Annual Income, $ -7,870 K
  • 36-Month Beta 6.13
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.62
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 08/16/18
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0082 +7.32%
on 08/15/18
0.0390 -77.44%
on 07/17/18
-0.0282 (-76.22%)
since 07/13/18
3-Month
0.0082 +7.32%
on 08/15/18
0.0780 -88.72%
on 06/08/18
-0.0587 (-86.96%)
since 05/15/18
52-Week
0.0082 +7.32%
on 08/15/18
0.7700 -98.86%
on 12/08/17
-0.4292 (-97.99%)
since 08/15/17

Most Recent Stories

More News
Propanc Biopharma Selected to Present at the 25th Annual NewsMakers in the Biotech Industry

Propanc Biopharma Inc. (OTCQB: PPCB) ("Propanc Biopharma" or the "Company"), a clinical stage biopharmaceutical company focusing on development of new and proprietary treatments for cancer patients suffering...

PPCHD : 1.2000 (+20.00%)
PPCB : 0.0088 (-12.00%)
Propanc Biopharma Selected to Present at the 25th Annual NewsMakers in the Biotech Industry

MELBOURNE, Australia , Aug. 9, 2018 /PRNewswire/ --  Propanc Biopharma Inc. (OTCQB: PPCB) ("Propanc Biopharma" or the "Company"), a clinical stage biopharmaceutical company focusing on development...

PPCB : 0.0088 (-12.00%)
Propanc Biopharma Enters National Phase for Two Key Patents

MELBOURNE, Australia , July 26, 2018 /PRNewswire/ --  Propanc Biopharma Inc. (OTCQB: PPCB) ("Propanc Biopharma" or the "Company"), a clinical stage biopharmaceutical company focusing on development...

PPCB : 0.0088 (-12.00%)
Biotech's Making Great Progress

FN Media Group Presents Microcapspeculators.com News Commentary

NURO : 1.20 (unch)
CLBS : 5.03 (-1.18%)
STML : 15.20 (-1.30%)
PPCB : 0.0088 (-12.00%)
VSTM : 8.02 (unch)
Innovative Biotech Companies, Preparing for the Future

LAS VEGAS, NV / ACCESSWIRE / June 15, 2018 / Some innovative biotechnology companies that are working on ground-breaking technology and are prepared for the future include: Propanc Biopharma, Inc. (OTCQB:...

CLDX : 0.42 (-2.33%)
PPCHD : 1.2000 (+20.00%)
AQXP : 2.85 (-12.58%)
PPCB : 0.0088 (-12.00%)
CPRX : 2.87 (-0.69%)
Innovative Biotech Companies Pushing the Envelope

FN Media Group Presents Microcapspeculators.com News Commentary

EBIO : 3.29 (+24.15%)
PACB : 4.28 (-5.52%)
VVUS : 0.63 (-3.08%)
PPCB : 0.0088 (-12.00%)
ATHX : 1.95 (-4.88%)
Analysts Predict Big Year in Biotech M&A

FN Media Group Presents Microcapspeculators.com News Commentary

AVXL : 2.66 (-4.66%)
PPCB : 0.0088 (-12.00%)
OPK : 5.26 (-2.23%)
PSTI : 1.25 (-1.57%)
IMMU : 21.70 (-3.43%)
New Report Released on Growing Biotech Sector

FN Media Group Presents Microcapspeculators.com News Commentary

DRNA : 14.53 (-1.96%)
PPCHD : 1.2000 (+20.00%)
IONS : 49.65 (-2.69%)
PPCB : 0.0088 (-12.00%)
CASI : 7.60 (-3.31%)
INSM : 21.00 (-0.10%)
Companies that Stand to Benefit from the Biotech Market Bottoming

FN Media Group Presents Microcapspeculators.com News Commentary

SRNE : 5.05 (-0.98%)
CELG : 89.27 (-3.71%)
CBAY : 11.95 (-3.94%)
ECYT : 16.49 (+0.83%)
PPCB : 0.0088 (-12.00%)
Propanc Biopharma Completes Scientific Advice Meeting with MHRA

MELBOURNE, Australia , April 10, 2018 /PRNewswire/ --  Propanc Biopharma Inc. (OTCQB: PPCB) ("Propanc Biopharma" or the "Company"), a clinical stage biopharmaceutical company focusing on development...

PPCB : 0.0088 (-12.00%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Sell with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Trade PPCB with:

Key Turning Points

2nd Resistance Point 0.0121
1st Resistance Point 0.0105
Last Price 0.0088
1st Support Level 0.0077
2nd Support Level 0.0065

See More

52-Week High 0.7700
Fibonacci 61.8% 0.4790
Fibonacci 50% 0.3891
Fibonacci 38.2% 0.2992
Last Price 0.0088
52-Week Low 0.0082

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar